Related Experiment Video
Updated: Jul 25, 2026

Comparative Analysis of Human Growth Hormone in Serum Using SPRi, Nano-SPRi and ELISA Assays
Published on: January 7, 2016
Estrogen priming effect on growth hormone (GH) provocative test: a useful tool for the diagnosis of GH deficiency
A S Martínez1, H M Domené, M G Ropelato
1División de Endocrinología, Centro de Investigaciones Endocrinológicas, Hospital de Niños R. Gutiérrez, Buenos Aires, Argentina. cedie@cedie.guti.gov.ar
Insights
Estradiol (E2) priming significantly enhances growth hormone (GH) stimulation tests in children with short stature (SS). This improves the accuracy of diagnosing GH deficiency, aiding in distinguishing normal from abnormal GH status.
Area of Science:
- Pediatric Endocrinology
- Growth Hormone Axis Research
- Diagnostic Test Optimization
Background:
- The growth hormone-insulin-like growth factor (GH-IGF) axis is crucial for growth in children.
- Accurate diagnosis of GH deficiency (GHD) and idiopathic short stature (SS) is essential for appropriate treatment.
- Estrogen's role in modulating the GH-IGF axis requires further elucidation, particularly in diagnostic contexts.
Purpose of the Study:
- To investigate the effect of estradiol (E2) priming on the GH-IGF axis in children with GHD and SS.
- To evaluate the diagnostic efficiency of GH stimulation tests with and without E2 priming.
- To determine if E2 priming can improve the discrimination between normal and abnormal GH status in children with SS.
Main Methods:
- A study involving 15 prepubertal GHD children and 44 prepubertal/early pubertal SS children.
- Administration of micronized E2 (1 or 2 mg daily) or placebo for 3 days prior to arginine-clonidine testing.
- Measurement of GH, IGF-I, and IGF binding protein-3 (IGFBP-3) levels to assess responses.
Main Results:
- E2 priming significantly increased maximal GH responses in SS children (17.8 ± 10.9 on placebo vs. 27.9 ± 14.5 µg/L on E2, P < 0.0001).
- E2 priming enhanced diagnostic efficiency for GH stimulation tests in SS children, increasing the cut-off limit and improving sensitivity and specificity.
- E2 had minimal impact on IGF-I levels but showed a small, significant increase in IGFBP-3 in GHD children.
Conclusions:
- GH stimulation tests with E2 priming demonstrate higher diagnostic efficiency, particularly for children with short stature.
- E2 priming reduces false non-responders, aiding in better discrimination of GH status in SS children.
- Estrogen priming appears to be a valuable adjunct for optimizing GH stimulation testing in pediatric populations.
Abstract:
We have studied the effect of estradiol (E2) on the GH-insulin-like growth factor (GH-IGF) axis in 15 prepubertal GH deficiency (GHD) children and 44 prepubertal or early pubertal children with idiopathic short stature (SS). All of them received a daily dose of micronized E2 (1 or 2 mg) or placebo, for 3 days, before a sequential arginine-clonidine test. In SS children, GH maximal responses were 17.8+/-10.9 on placebo and 27.9+/-14.5 microg/L on estrogen (P < 0.0001). The lower 95% confidence limits for GH maximal response changed from 3.7 microg/L (without E2) to 8.3 microg/L (on E2). In GHD children, no significant stimulatory effect of estrogen on GH levels was observed. After placebo, a cut-off limit of 3.7 microg/L (the lower 95% confidence interval limit) resulted in 73% sensitivity, 95% specificity, and an overall 90% diagnostic efficiency. After E2, a cut-off limit of 8.3 microg/L resulted in a sensitivity of 87%, a specificity of 98%, and a diagnostic efficiency of 95%. After placebo, 68% of SS showed normal IGF-I levels, and the mean did not change on E2 (13.7+/-6.3 vs. 14.3+/-6.8 nmol/L, not significant). In 93% of SS, IGF binding protein (IGFBP)-3 levels were normal during placebo. On E2, mean IGFBP-3 did not change (2.63+/-0.70 vs. 2.70+/-0.70 mg/L, not significant). In 14 of 15 GHD patients, IGF-I values were below normal on placebo, and the mean of the group did not change after E2. During placebo, 13 of 15 GHD children presented low IGFBP-3 values. During E2, there was a small significant increase in IGFBP-3 values (1.06+/-0.58 vs. 1.20+/-0.69 mg/L, P < 0.02). The highest diagnostic efficiencies for IGF-I and IGFBP-3 were observed during placebo (75% and 91%, respectively). We conclude that GH stimulation tests after E2 priming had the highest diagnostic efficiency. Our findings suggest that the effect of estrogen priming on GH stimulated levels, by reducing the number of false nonresponders, might be useful to better discriminate between normal and abnormal GH status in SS children.
More Related Videos
07:30Homogeneous Time-resolved Förster Resonance Energy Transfer-based Assay for Detection of Insulin Secretion
Published on: May 10, 2018
06:18An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
Published on: August 13, 2019
Related Concept Videos
Myasthenia Gravis: Diagnostic Tests
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
Hormones of the Pituitary Gland
The most abundantly secreted hormone from the anterior lobe is the growth hormone, which controls overall growth by...
Gonadal and Placental Hormones
In males, testosterone is the primary gonadal androgen. It plays a central role in the maturation of male reproductive organs — the penis and testes. Additionally, testosterone is instrumental in the development of secondary sexual characteristics — a deep voice as well as facial and pubic hair growth — and...
Hormonal Regulation of the Menstrual Cycle
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH release.
Signs of Puberty
Major Hormones and Their Functions
Oxytocin, produced in the hypothalamus and released by the pituitary gland, plays a role in social bonding, childbirth, and lactation.